Suppr超能文献

用于多模式纳米医学的重组铁蛋白。

Recombinant ferritins for multimodal nanomedicine.

机构信息

College of Life Science, Yangtze University, Jingzhou, China.

Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové, Czech Republic.

出版信息

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2219868. doi: 10.1080/14756366.2023.2219868.

Abstract

In all living organisms, ferritins are a group of proteins important for maintaining iron homeostasis. Increasing amount of studies has shown that recombinant ferritins can be widely used in multimodal nanomedicine, especially for anticancer treatment and vaccination. Recombinant particles prepared by fusing viral proteins and ferritin subunits produce a better immune response and higher antibody titres. Moreover, actively-targeted ferritin nanoparticles can recognise receptors and deliver natural or chemical drugs specifically to the tumour tissue. In addition, ferritin-linked or loaded with contrast agents or fluorescent dyes can be used as multimodal particles useful cancer theranostics. In this review, we fully summarised the unitisation of recombinant ferritins in multimodal nanomedicine. The research progress of using recombinant ferritins as nanovaccines, nanozymes, and bioengineered nanocarriers for targeted therapy and bioimaging is emphasised.

摘要

在所有生物中,铁蛋白是一组对于维持铁稳态非常重要的蛋白质。越来越多的研究表明,重组铁蛋白可以广泛应用于多模态纳米医学,特别是在癌症治疗和疫苗接种方面。通过融合病毒蛋白和铁蛋白亚基制备的重组颗粒可产生更好的免疫反应和更高的抗体效价。此外,主动靶向铁蛋白纳米颗粒可以识别受体并将天然或化学药物特异性递送到肿瘤组织。此外,铁蛋白连接或负载对比剂或荧光染料可以作为多模态颗粒用于癌症治疗和诊断。在这篇综述中,我们全面总结了重组铁蛋白在多模态纳米医学中的应用。强调了将重组铁蛋白用作纳米疫苗、纳米酶和生物工程纳米载体进行靶向治疗和生物成像的研究进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1a/10236959/eadfe2a29421/IENZ_A_2219868_F0001_C.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验